Klaus Orlinger - 01 Feb 2022 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Executive VP, Research
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
Issuer symbol
HOOK
Transactions as of
01 Feb 2022
Net transactions value
+$65,526
Form type
4
Filing time
01 Feb 2022, 19:52:03 UTC
Next filing
20 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HOOK Common Stock Award $27,564 +9,188 +756% $3.00 10,404 01 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $37,962 +12,654 $3.00 12,654 01 Feb 2022 Common Stock 12,654 $1.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was awarded 9,188 unrestricted shares of common stock as a portion of their base salary for the six month ending June 30, 2022.
F2 This stock option is fully vested.